• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

AHAF launches 'See A Better Tomorrow' campaign

Article

The American Health Assistance Foundation (AHAF) has launched “See A Better Tomorrow,” a public education campaign that encourages people to schedule comprehensive eye exams to help protect against irreversible vision loss caused by glaucoma or age-related macular degeneration (AMD).

Clarksburg, MD-The American Health Assistance Foundation (AHAF) has launched “See A Better Tomorrow,” a public education campaign that encourages people to schedule comprehensive eye exams to help protect against irreversible vision loss caused by glaucoma or age-related macular degeneration (AMD).

AHAF attests that early diagnosis is key to limiting or preventing vision loss from these two degenerative diseases, which affect 16 million Americans.

“Many people are unaware that they have these diseases until they start to experience symptoms, after irreversible vision loss may have occurred,” said AHAF president and chief executive officer Stacy Pagos Haller. “The good news is that with detection and treatment, eye doctors can often slow or stop the progression of these diseases and help protect against blindness.”

Through public service announcements and a wide range of resources, AHAF’s campaign asks people to visualize places or people they want to see, and then to protect their ability to continue seeing them by having an eye exam. For more information on the multi-platform campaign, visit www.ahaf.org/seeabettertomorrow.

AHAF is a nonprofit organization dedicated to finding cures for age-related degenerative diseases by funding research worldwide under its three program areas: Alzheimer’s disease research, macular degeneration research, and national glaucoma research (www.ahaf.org). To date, AHAF’s macular degeneration research and national glaucoma research programs have provided more than $31.5 million in grants to identify new prevention, diagnostic, and treatment options for people facing vision loss.

For more articles in this issue of Ophthalmology Times eReport, click here.

Related Videos
Neda Nikpoor, MD, talks about the Light Adjustable Lens at ASCRS 2024
© 2024 MJH Life Sciences

All rights reserved.